Back to EICCI

Primer on Novel Immune-Based Approaches to Target Cancer Cells

February 15, 2019 from 8:00 am until 11:15 am.

All Attendees must present the Pre-Workshop Registration receipts upon arrival.

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Qatar Council for Healthcare Practitioners – Accreditation Department and is approved for a maximum of 3.25

Download Agenda

  • Learning Objectives

    At the end of the workshop, participants will be able to:

    • Define the concept of immune control of tumor growth and immunology
    • Recall the importance and the potency of the immune system to recognize and kill tumor cells 
    • Describe the technologies and clinical development of engineered immune cells 
    • Describe the clinical impact of registered anti-cancer bsAbs
  • Target Audience

    Research Scientists, Immunologists, Physicians, Medical Oncologists, Hematologists, Pediatric Oncologists, Medical and Research Fellows in Training, General Practitioners, Nurses, Pharmacists, Clinical Trial Research Staff, Cancer Patient’s Associations and Charities, Graduated and non-Graduated Students.
  • Speakers

    To view the Pre-Workshop Speakers, click here.